BEIJING (Global Times): The WHO's emergency approval of China's Covid-19 vaccine will boost global vaccine supply amid shortfall as China's overall yearly production capacity is approaching five billion doses, observers said. The WHO gave Emergency Use Listing (EUL) to Sinopharm's Covid-19 vaccine on Friday (May 7) afternoon, making it the sixth vaccine and the first made by a non-Western country to receive WHO validation for its safety, efficacy and quality. This will send a statement to Western media's doubts and questions over the vaccine's authenticity, observers noted. The other five Covid-19 vaccines previously approved by the WHO were made by Pfizer, AstraZeneca, Johnson & Johnson and Moderna.